smiling man in his fifties seated in a wheelchair, with a smiling woman standing behind him with her hands on his shoulders

Pioneering Implantable Neuromodulation for Neurogenic Erectile Dysfunction

Restoring neural signaling. Restoring sexual health.

CaverSTIM™ is an investigational implantable neuromodulation system designed to restore neural signaling by stimulating the activation and rehabilitation of the neural pathways responsible for erection.

The technology is currently being evaluated in men with neurogenic erectile dysfunction, initially through clinical studies in spinal cord injury, while additional research continues in post-prostatectomy erectile dysfunction.

With support from:

EPFL Swiss Innovation Agency Canton de Vaud IMD Venture TOP2 Venture Leaders

Understanding Neurogenic Erectile Dysfunction

  1. Step 1

    Neurological Injury

    Neurogenic erectile dysfunction occurs when injury or damage disrupts the neural pathways responsible for erection.

  2. Step 2

    Disrupted Neural Signaling

    When communication between the nervous system and erectile tissue is interrupted, erectile function may be impaired.

  3. Step 3

    Current Treatment Landscape

    Current therapies improve blood flow or mechanically produce erections but do not restore the disrupted neural signals responsible for initiating erection.

  4. Step 4

    A New Therapeutic Approach

    Unlike therapies that compensate for erectile dysfunction, CaverSTIM is designed to support and restore neural signaling through targeted implantable neuromodulation.

Understanding CaverSTIM™

Learn more about how our medical technology works

Designed to Stimulate the Neural Pathways Responsible for Erection

CaverSTIM™ is an investigational implantable neurostimulation system designed to activate and restore the neural pathways responsible for erection. By delivering precisely programmed electrical pulses to the nerves involved in erectile function, the technology is intended to support neural signaling in men living with neurogenic erectile dysfunction.

The device combines implantable electrodes, a rechargeable pulse generator, a patient remote control and a clinician programmer to deliver personalized neurostimulation over time. CaverSTIM is currently being evaluated in clinical studies across multiple neurogenic erectile dysfunction indications.

CaverSTIM physician programmer device

Advanced Neuromodulation Technology

Built on established neuromodulation principles, CaverSTIM™ delivers targeted electrical stimulation to the neural pathways responsible for erection. Therapy parameters can be individualized to modulate neural activity while allowing clinicians to tailor treatment to each patient's needs.

Unlike conventional neurostimulation systems that require precise placement on a single nerve, CaverSTIM™ uses a proprietary multi-electrode interface designed to accommodate natural anatomical variability. This allows clinicians to identify personalized stimulation patterns tailored to each patient.

Robotic-assisted surgical arm with CaverSTIM's implantable components labeled
  • Targeted stimulation of neural pathways involved in erectile function
  • Implantable electrode array designed for precise nerve interface
  • Rechargeable pulse generator with programmable stimulation settings
  • Clinician-controlled programming for individualized therapy

CaverSTIM™ combines three integrated components that work together to deliver personalized neurostimulation therapy designed to stimulate the neural pathways responsible for erection.

Multi-Electrode Interface

Designed to broadly engage the pelvic neural network despite natural anatomical variability.

Pulse Generator

A rechargeable implantable pulse generator delivering programmable neurostimulation tailored to each patient.

Personalized Therapy

Stimulation parameters are tailored to each patient's unique neural anatomy and recovery.

Patient Journey

  1. Surgery

  2. Programming

  3. Daily Sub-sensory Stimulation

  4. On-demand Activation

Surgery

CaverSTIM is implanted through minimally invasive laparoscopic surgery, which may be robot-assisted. The implant is fully contained within the body, with electrodes positioned on the nerves involved in erectile function and the stimulator placed under the skin.

Programming

A few days after surgery, the medical team adjusts the stimulation settings for each patient. The patient controller is then programmed for easy, personalized use.

Daily Sub-sensory Stimulation

Patients use CaverSTIM for one hour each day at sub-sensory stimulation. This daily routine is designed to help stimulate and retrain the nerves involved in erectile function.

On-demand Activation

When desired, patients can activate a dedicated stimulation program to support erectile function during sexual activity. The therapy is controlled directly by the patient.

Clinical Development

  • Initial clinical studies in spinal cord injury
  • Defined patient population
  • Strong biological rationale
  • Significant unmet medical need

Patients

  • Drug-free therapy
  • Patient-controlled activation
  • Designed to stimulate neural pathways involved in erectile function
  • Focused on improving quality of life

Future Development

  • Continued development in post-prostatectomy erectile dysfunction
  • Building on the neurogenic ED platform
  • Expanding clinical evidence
  • Advancing long-term innovation

Clinical Development

Grounded in Clinical Evidence. Advancing the Future of Neurogenic Erectile Dysfunction.

Clinical studies are evaluating CaverSTIM™ in men living with neurogenic erectile dysfunction, beginning with spinal cord injury.

Early Clinical Evidence – First-In-Human Study

  • No device-related infections reported
  • No device removals reported
  • Clinically meaningful improvements in erectile function
  • 83% of men living with SCI achieved clinically meaningful improvements far above established thresholds
  • 90% erectile function recovery observed in the initial post-prostatectomy cohort

Early findings support continued clinical development of CaverSTIM™ as a novel neuromodulation therapy for neurogenic erectile dysfunction.

Our Mission

To restore sexual health and improve quality of life for men living with neurogenic erectile dysfunction through innovative implantable neuromodulation.

Our Vision

To redefine the standard of care for neurogenic erectile dysfunction and become the global leader in implantable neuromodulation therapies for sexual health.